Searched for
CHINA PHARMA SUPPLY CHAIN
Need to de-risk single-point failures in global AI supply chains: US officialAccording to a high-ranking official from the US, there is a strong partnership between India and the US in fortifying global AI supply cha...- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Climate-related disruptions affecting MSMEs' productivity, operations, supply chains: ReportA new report reveals a stark 'actionability gap,' as most businesses rely on reactive measures instead of proactive resilience. This vulner...
- Building resilient supply chains through an India-Chile partnershipChile, a major global player in critical minerals like copper and lithium, presents a compelling strategic alliance opportunity for India. ...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- The China reality check: Why India needs calibrated engagementIndia and China are set for increased engagement, with New Delhi aiming to strategically leverage its industrial reliance on Beijing. Follo...
- Chinese EV makers are shut out of India - but their tech isn'tDespite India's restrictions on Chinese automakers, their electric vehicle technology is finding its way into the Indian market. Tata Motor...
- Chinese EV makers are shut out of India - but their tech isn'tDespite India's restrictions on Chinese automakers, their electric vehicle technology is finding its way into the Indian market. Tata Motor...
- NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chainNiti Aayog proposes a blueprint for free trade agreements to boost regulatory predictability in India's pharmaceutical sector. The think ta...
- Hormuz reopening to ease supply chains, strengthen energy security: DovalIndia expressed cautious optimism regarding the US-Iran understanding and the reopening of the Strait of Hormuz, according to National Secu...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
- Critical minerals, strategic stakes: Inside India's bid to break China's supply chain strangleholdIndia and the US have inked a pact to secure critical mineral supplies, bolstering a broader Quad initiative aiming to invest $20 billion i...
- China warns of fragmented supply chains as trade tensions growBeijing, a dominant supplier, has retaliated against potential restrictions with export controls. While China attributes its competitivenes...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Data centers are stewing in their own pollutionA new study reveals a significant portion of planned data centers face high climate risks, potentially becoming uninsurable due to extreme ...
- Trump offers Wall Street talent a Prez pay of $400k to bolster US national security supply chainsThe Trump administration is hiring 400 dealmakers to boost US national security supply chains. Top finance professionals will receive salar...
- How India can win in a rewired global economyIndia is poised to gain from global supply chain shifts. Strategic neutrality and domestic focus are key. The nation must build robust buff...
- China's rare-earth export value jumps 44.9% in Jan-May despite modest rise in volumesChina's rare-earth exports saw a modest 2.2% volume increase in early 2026, but export value surged by 44.9% to $243.63 million. This signi...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- Compliance complexity is the defining challenge amid tariff uncertainties: Maersk Asia Pacific surveyVietnam, Thailand, and India emerge as key multi-country hubs. AI adoption is high, but integration with compliance platforms is crucial fo...
Load More
